journal article·2019-09-02

A novel bilayer drug-loaded wound dressing of PVDF and PHB/Chitosan nanofibers applicable for post-surgical ulcers

Fatemeh Amini, Dariush Semnani, Saeed Karbasi, Seyedeh Nooshin Banitaba

Publisher page

Abstract

A novel bilayer nanofibrous wound dressing, with enhanced mechanical properties is successfully fabricated. This membrane, consisted of polyvinylidenefluoride (PVDF) nanofibers for providing tensile strength and polyhydroxybutyrate/chitosan (PHB/CTS) nanofibers loaded with gentamicin with ability of controlled drug delivery, is a great choice for post-surgical ulcers. Mechanical properties showed dramatically improvement of tensile strength by addition of PVDF layer. Gentamycin release represented both an immediate and a sustained release of about 24 h and 1 week, respectively and release increment with increase of CTS ratio. Results also revealed that drug release in structures follow first order kinetic and Fickian release mechanism.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of textile engineering, Isfahan University of Technology, Isfahan, Iran;

Department of Biomaterials and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

References (30)

Show source-provided references
1. Kore S. · J Postgrad Med · 2000 · 46 · 26
2. 10.1046/j.1524-475X.1994.20305.x10.1046/j.1524-475X.1994.20305.x ↗
3. 10.1002/pat.162510.1002/pat.1625 ↗
4. 10.1016/S1067-2516(97)80003-810.1016/S1067-2516(97)80003-8 ↗
5. 10.1002/jps.2121010.1002/jps.21210 ↗
6. 10.1089/wound.2014.058610.1089/wound.2014.0586 ↗
7. 10.1002/mabi.20130056110.1002/mabi.201300561 ↗
8. 10.1002/jbm.b.1005810.1002/jbm.b.10058 ↗
9. 10.3390/ijms1109352910.3390/ijms11093529 ↗
10. 10.2217/nnm-2017-001710.2217/nnm-2017-0017 ↗
11. 10.1039/C4CS00226A10.1039/C4CS00226A ↗
12. 10.1016/j.actbio.2007.01.00210.1016/j.actbio.2007.01.002 ↗
13. 10.1002/mabi.20130005810.1002/mabi.201300058 ↗
14. 10.1073/pnas.121549811010.1073/pnas.1215498110 ↗
15. 10.1016/j.jconrel.2014.04.01810.1016/j.jconrel.2014.04.018 ↗
16. 10.1002/pen.2370410.1002/pen.23704 ↗
17. 10.1016/S1369-703X(03)00038-X10.1016/S1369-703X(03)00038-X ↗
18. 10.1016/j.nanoen.2017.11.02310.1016/j.nanoen.2017.11.023 ↗
19. 10.1021/bm100912v10.1021/bm100912v ↗
20. 10.1016/j.carbpol.2012.12.04310.1016/j.carbpol.2012.12.043 ↗
21. 10.1016/j.colsurfa.2007.04.12910.1016/j.colsurfa.2007.04.129 ↗
22. 10.1002/app.4417110.1002/app.44171 ↗
23. 10.1002/app.1205510.1002/app.12055 ↗
24. 10.1016/S0142-9612(96)00114-710.1016/S0142-9612(96)00114-7 ↗
25. 10.1016/j.colsurfb.2015.04.02610.1016/j.colsurfb.2015.04.026 ↗
26. 10.1002/jbm.82029120910.1002/jbm.820291209 ↗
27. 10.1081/DDC-12002417910.1081/DDC-120024179 ↗
28. Dash S. · Acta Pol Pharm · 2010 · 67 · 217
29. 10.1517/1742524100360225910.1517/17425241003602259 ↗
30. 10.1016/S0939-6411(99)00058-210.1016/S0939-6411(99)00058-2 ↗